Abstract
Alzheimer’s disease will be the epidemic of the twenty-first century (1,2). The generally accepted figures are that 5% of individuals of the age of 65 have severe dementia, and another 10% have moderate dementia, with 30% having developed dementia if they live to the age of 90. The recent Boston study suggested that the figures were even higher, with 3% of those age 65 to 74 having probable Alzheimer’s disease, 18.7% of those 75 to 84, and 47.2% of those over 85 having probable Alzheimer’s disease (3). About 75% of patients with a clinical diagnosis of senile dementia prove to have Alzheimer’s disease, while a number of other disorders, such as multi-infarct dementia and other neurological degenerations, underlie the remaining proportion. Alzheimer’s disease is therefore going to be the major health care burden in the coming decades, both in terms of personal and family stress and of national health care costs. It is unnecessary, therefore, to emphasize the urgent need for an understanding of the cause of the disease and its treatment.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Katzman, R. (1983). Demography, definitions and problems, Ch. 1 in: The Neurology of Aging. (eds) Katzman, R. and Terry, R. D., David, F. A., Philadelphia.
Plum, F. (1979). Dementia: An approaching epidemic. Mature, 279: 373–373.
Evans, D. A., Funkenstein, H. H., Albert, M. S. (1989). Prevalence of Alzheimer’s disease in a community population of older persons. JAMA, 262: 2551–2556.
Bick, K., Amaducci, L., Pepen, G. (1987). The Early Story of Alzheimer’s Disease. Liviana Press, Padova.
Editorial (1987). Alzheimer’s disease and associated disorders, Vol 1, pp. 1–4.
Hansen, L. A., DeTeresa, R., Davies, D. (1988). Neocortical morphometry, lesion count, and choline acetyltransf erase levels in the age spectrum of Alzheimer’s disease, Neurol.. 38: 48–54.
Schiebel, A. B. and Tomiyasu, V. (1978). Dendritic sprouting in Alzheimer’s presenile dementia. Exper. Neurol., 60:1–8.
Hamos, J. E., DeGennaro, L. J., Drachman, D. A. (1989). Synaptic loss in Alzheimer’s disease and other dementias. Neurol., 39: 355–361.
Cutler, N. R., Haxby, J. V., Duara, R. (1985). Clinical history, brain metabolism and neuro-psychological function in Alzheimer’s disease, Ann. Neurol. 18: 298–309.
Coyle, J. T., Price, D. L., Delong, M. R. (1983). Alzheimer’s disease: a disorder of cortical cholinergie innervation. Science, 219: 1184–1189.
Carlson, A. (1983). Changes in neurotransmitter systems in the aging brain and in Alzheimer’s disease. Ch 13 in Alzheimer’s Disease, eds: Reisberg, B., Free Press, New York.
Davies, P. (1983). An update on the neurochemistry of Alzheimer’s disease, pp. 75–86 in: Advances in Neurology, 38 The Dementias. Eds: Mayeux, R. and Rosen, W. G., Raven Press, New York.
Francis, P. T., Palmer, A. M., Sims, N. R. (1985). Neurochemical studies of early onset Alzheimer’s disease. New Engl. J. Med., 313: 7–11.
Ferrier, I. N., Cross, A. J., Johnson, J. A. (1983). Neuropeptides in Alzheimer’s type dementia. J. Neurol. Sci., 62: 159–170.
Waters, C. (1988). Cognitive enhancing agents: Current status in the treatment of Alzheimer’s disease. Can. J. Neurol. Sci., 15: 249–256.
Perry, G., Rizzuto, N., Autilio-Gambetti, L. (1985). Paired helical filaments from Alzheimer’s disease patients contain cytoskeletal components. Proc. Nat. Acad. Sci., 82: 3916–3920.
Grundke-Iqbal, I., Johnson, A. B., Wisniewski, H. M. (1979). Evidence that Alzheimer’s disease neurofibrillary tangles originate from neurotubules. Lancet, 1: 578–580.
Selkoe, D. J., Abraham, C. R., Podlisny, M. D. (1986). Isolation of low molecular-weight proteins from amyloid plaque fibers in Alzheimer’s disease. J. Neurochem, 46: 1820–1834.
Blessed, G., Tomlinson, B. E., Roth, M. (1968). The association between quantitative measures of dementia and of senile changes in the cerebral grey matter of elderly subjects. Brit. J. Psychiat., 114: 797–811.
Khachaturian, Z. S. (1985). Diagnosis of Alzheimer’s disease. Arch. Neurol., 42: 1097–1105.
Crapper, D. R., Quittkat, S., Krishnan, S. S. (1980). Intranuclear aluminum content in Alzheimer’s disease, dialysis encephalopathy and experimental aluminum encephalopathy. Acta Neuropath. (Berl.), 50: 1924.
O’Hare, J. A., Callaghan, N. M. (1983). Dialysisencephalopathy. Medicine, 62: 129–141.
Crapper, D. R., Karlik, S. and De Boni, V. (1978). Aluminum and other metals in senile (Alzheimer’s) dementia, pp. 471–484, in Alzheimer’s disease: Senile dementia and related disorders. Aging (Vol. 7). Eds: Katzman, R., Terry, R. D., Bick, K. L. Raven Press, N.Y.
Schwartz, A. S., Frey, J. L., Lukas, R. J. (1988). Risk factors in Alzheimer’s disease: Is aluminum hazardous to your health? Barrow Neurol. Inst. Quart., 4: 2–8.
Perl, D. P., Gajdusek, D. C., Garruto, R. M. (1982). Intraneuronal aluminum accumulation in amyotrophic lateral sclerosis and Parkinsonismdementia of Guam. Science, 217: 1053–1055.
Perl, D. P. (1983). Pathologic association of aluminum in Alzheimer’s disease,) Ch 15 in: Alzheimer’s Disease. Ed: Reisberg, B., Free Press, New York.
Pendlebury, W. W., Beal, M. F., Kowall, N. W. (1988). Neuropathologic, neurochemical and immunocytochemical characteristics of aluminum-induced neurofilamentous degeneration. Neurotoxicology, 9: 503–510.
Pendlebury, W. W., Munos-Garcia, D., Perl, D. P. (1987). Cytoskeletal pathology in neuro-degenerative diseases. In: (eds) Ehlich, Y. H., Lenox, R. H., Koraecki, E., Molecular mechanisms of neuronal responsiveness. Plenum Press, New York, pp. 427–442.
Solomon, P. R., Beal, M. F., Pendlebury, W. W. (1988). Age-related description of classical conditioning: A model system approach to memory disorders. Neuroseology of Aging, 9: 535–546.
Peterson, C., Goldman, J. E. (1986). Alterations in calcium content and biochemical processes in cultured skin fibroblasts from aged and Alzheimer donors. Proc. Nat. Acad. Sci., 83: 2758–2762.
Tsubaki, T., Yase, Y. (eds) (1988). Amyotrophic lateral sclerosis, Excerpta Medica Int. Conf. Series 769, Amsterdam.
Spencer, P. S., Palmer, V., Ohta, M. (1988). Cycad, a suspect etiological factor for Guam ALS/PD, is associated with motor neuron disease in Irian Jaya, Indonesia and Kii peninsula, Japan, pp. 35–40. In: Tsubaki, T. and Yase, Y. (eds): Spencer, P. S., Palmer, V., Ohta, M 769, Amsterdam.
Plaitakis, A., Caroscio, J. T. (1987). Abnormal glutamate metabolism in amyotrophie lateral sclerosis. Neurol., 22: 575–579.
Martyn, C. N., Osmond, C., Wardson, J. A. (1989). Geographical relation between Alzheimer’s disease and aluminum in drinking water. Lancet, 59–62.
Editorial, The Lancet,January 14, 1989. Aluminum and Alzheimer’s disease, 82–83.
Heston, L. L., Mastri, A. R., Anderson, V. E. (1981). Dementia of the Alzheimer’s type. Arch. Gen. Psych., 38: 1085–1090.
Heston, L. L. (1983). Genetic studies of dementia, Ch 6 in The Epidemiology of Dementia. Eds: Mortimer, J. A., Schuman, L. M., Oxford Univ. Press, New York, 101–114.
Nee, L. E., Polinsky, R. J., Eldridge, R. (1983). A family with histologically confirmed Alzheimer’s disease. Arch. Neurol., 40: 203–208.
Matsuyama, S. S. (1983). Genetic factors in dementia of the Alzheimer-type. Ch 21 in Alzheimer’s Disease. Ed: Reisberg, B., Free Press, New York, 155–160.
Farrer, L. A., O’Sullivan, D. M., Cupples, L. A. (1989). Assessment of genetic risk for Alzheimer’s disease among first degree relatives. Ann. Neurol., 25: 485–493.
Wisniewski, K. E., Wiskiewski, H. M., Wen, G. Y. (1985). Occurrence of neuropathological changes and dementia of Alzheimer’s disease in Down’s syndrome. Ann. Neurol., 17: 278–282.
Editorial (1987). Alzheimer’s Disease, Down’s syndrome and Chromosome 21. Lancet, 1: 1011–1012.
Hardy, J. (1988). Molecular biology and Alzheimer’s disease. TINS, 11: 293–294.
Tanzi, R. E., Gusella, J. F., Watkins, P.C. (1987). Amyloid B protein gene: cDNA, mRNA distribution and genetic linkage near the Alzheimer’s locus. Science, 235: 880–884.
St. George-Hyslop, P. H., Tanzi, R. E., Polinski, R. J. (1987). The genetic defect causing familial Alzheimer’s disease maps to chromosome 21. Science, 235: 885–890.
Mann, D. M. A., Yates, P. O. (1974). Motor neuron disease. J. Neurol. Neurosurg. Psychiat., 37: 1036–1047.
Mann, D. M. A., Neary, D., Yates, P.O. (1981). Alterations in the protein synthetic capability of nerve cells in Alzheimer’s disease. J. Neurosurg. Psychiat., 44: 97–105.
Mann, D. M. A., Yates, P.O. (1983). Pathological basis of neuro-transmitter changes in Parkinson’s disease. Neuropath. Exp. Neurobiol., 8: 3–14.
Lewis, P. N., Lukin, W. J., DeBoni, V. (1981). Changes in chromatin structure associated with Alzheimer’s disease. J. Neurochem., 37: 1193–1202.
Crapper-McLachlan, D. R., Lewis, P. N., Lukiw, W. J. (1984). Chromatin structure in dementia. Ann. Neurol., 15: 329–334.
Crapper-McLachlan, D. R., Lewis, P. N. (1985). Alzheimer’s disease: errors in gene expression. Canadian J. Neurol. Sci., 12: 1–5.
Robbins, J. H. (1978). ICN-UCLA Symposia on molecular and cellular biology, Vol IX, Academie Press, 603–629.
Andrews, A. D., Carrett, S. R., Robbins, J. H. (1978). Xeroderna pigmentosum: Neurological abnormalities correlate with colony forming ability after UV-radiation. Proc. Nat. Acad. Sci., 75: 1984–1988.
Robbins, J. H., Otswka, F., Tarone, R. E. (1983). Radiosensitivity in Alzheimer’s disease and Parkinson’s disease. Lancet, 1: 468–469.
Robinson, S. H., Munzer, J. S., Tandan, R. (1987). Alzheimer’s disease cells have defective repair of alkylating agent-induced DNA damage. Ann. Neurol., 21: 250–258.
Tandan, R., Robison, S. H., Bartlett, J. D. (1988). DNA damage and repair in ALS and Alzheimer’s disease lymphoid cells and monocytes. In: Amyotrophic Lateral Sclerosis. Eds: Tsubaki, T., Yase, Y., Elsevier, New York, 113–118.
Wetmur, J. G., Casals, J., Elizan, T. S. (1984). DNA binding protein, profiles in Alzheimer’s disease. J. Neurol. Sci., 66: 201–208.
Mullaart, E., Boerrigter, M. E. T., Ravid, R. (1989). Increased levels of DNA breaks in cerebral corte of Alzheimer’s disease patients. In press.
Sajdel-Sulkowska, E. M., Marotta, C. A. (1984). Alzheimer’s disease brain: Alterations in RNA levels and in a ribonuclease-inhibitor complex, Science, 225: 947–949.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1990 Plenum Press, New York
About this chapter
Cite this chapter
Bradley, W.G. (1990). Alzheimer’s Disease: Theories of Causation. In: Zandi, T., Ham, R.J. (eds) New Directions in Understanding Dementia and Alzheimer’s Disease. Advances in Experimental Medicine and Biology, vol 282. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-0665-8_3
Download citation
DOI: https://doi.org/10.1007/978-1-4613-0665-8_3
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4612-7917-4
Online ISBN: 978-1-4613-0665-8
eBook Packages: Springer Book Archive